InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Evanson Jeff, Directeur Commercial. Officer active across 1 companies, notably Outlook Therapeutics, Inc.. Aggregated, 2 reports have been recorded. Total volume traded: €83k. The latest transaction was filed on 3 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€41,71935,200 shares@ €1.18520.15% mcap100.0% of flow
Common Stock
SEC:0001209191-21-068134·
Ideal exit: 30 Aug 2022 (T+270)
€41,71935,200 shares@ €1.18520.15% mcap50.0% of flow
Common Stock
SEC:0001209191-21-068134:0·
Ideal exit: 30 Aug 2022 (T+270)
2 of 2 declarations
About Evanson Jeff
Jeff Evanson is the Chief Commercial Officer at Outlook Therapeutics, Inc. He is responsible for business strategy and development. His role includes identifying market opportunities and managing sales teams.
